| Ytd | -37.08% | |
| 1y | 6.40% |
| Open | Prev Close | 108.62 | Low | High | Mkt Cap | 23.54B | |||
| Vol | 636.00 | Avg Vol | 3.83M | EPS | -5.75 | P/E | -18.89 | Forward P/E | 16.37 |
| Beta | 0.78 | Short Ratio | 3.20 | Inst. Own | 105.25% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 105.79 | 200-d Avg | 149.85 | 1yr Est | 196.38 |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analys
Top Wall Street analysts change outlook on top stocks. For analyst rating changes, see https://www.b
Wall Street analysts are making bold moves on Tuesday, shaking up ratings for some of the biggest na
BMO Capital analyst Connor Mackay initiates coverage on Insmed (NASDAQ:INSM) with a Outperform ra
Stanley Druckenmiller doesn't do consensus. The Duquesne Family Office's latest 13F reveals a top-fi
Bank of New York Mellon Corp lessened its stake in shares of Insmed, Inc. (NASDAQ: INSM) by 9.2% dur
Insmed Incorporated (INSM) Discusses 12-Month Results From Ongoing TPIP Open-Label Extension Study i
Insmed Incorporated (NASDAQ:INSM) on Thursday reported 12-month results from the ongoing open-label
Insmed reports 12-month TPIP extension data showing sustained efficacy and favorable safety in PAH a
Insmed NASDAQ: INSM reported 12-month results from an ongoing open-label extension study of TPIP in
–12-Month Data Demonstrated Sustained Improvement with TPIP Across All Secondary Efficacy Measures I
– 12-Month Data Demonstrated Sustained Improvement with TPIP Across All Secondary Efficacy Measures
Wells Fargo analyst Benjamin Burnett maintains Insmed (NASDAQ:INSM) with a Overweight and raises
Evercore ISI Group analyst Josh Schimmer maintains Insmed (NASDAQ:INSM) with a Outperform and low
Nebius Group N.V. (NASDAQ: NBIS) stock surged on Tuesday after confirming its upcoming addition to t
CoreWeave, Astera Labs, Nebius, Rocket Lab & Teradyne join the Nasdaq-100. Jim Cramer calls this
CRWV stock climbs 5% as CoreWeave gears up to join the Nasdaq-100. Get the latest price action, incl
Wall Street analysts change outlook on top names. B of A cuts CPB, UBS cuts AJG PT, B of A boosts OR
Top analysts changed their views on top stocks. For all changes, upgrades and downgrades, see analys
ZBRA, VSTS, AMBQ, VPG, BAK, PACS, LOT, EIKN, DDD, WEN, SIBN post significant gains on better-than-ex
Weak earnings, soft guidance and analyst target cuts triggered sharp selloffs across healthcare, sof
U.S. stocks drifted near records Thursday as oil slipped on Iran-Hormuz peace hopes. Coinbase, Airbn
Analysts change ratings & price targets for HSCS, ONDS, STRO, PFE, HST, CABA, INSM, PVH. See ful
The Nasdaq-100 Index has announced its annual reconstitution, with six new companies being added and
As a result of the reconstitution, the following six companies will be removed from the Index: Bioge
Companies Reporting Before The Bell • PG&E (NYSE:PCG) is likely to report quarterly earnings